Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

? Special Offer?Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

? New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Cabiralizumab Biosimilar – Anti-CSF1R, CD115 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG4, Kappa

€200.00

100ug +200 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
Cabiralizumab Biosimilar - Anti-CSF1R, CD115 mAb - Research Grade

Cabiralizumab Biosimilar - Anti-CSF1R, CD115 mAb - Research Grade

Product name Cabiralizumab Biosimilar - Anti-CSF1R, CD115 mAb - Research Grade
Source CAS 1613144-80-1
Species Humanized
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Cabiralizumab,FPA-008,CSF1R, CD115,anti-CSF1R, CD115
Reference PX-TA1408
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody
Product name Cabiralizumab Biosimilar - Anti-CSF1R, CD115 mAb - Research Grade
Source CAS 1613144-80-1
Species Humanized
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Cabiralizumab,FPA-008,CSF1R, CD115,anti-CSF1R, CD115
Reference PX-TA1408
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody

General information on Anti-CSF1R/CD115[Homo sapiens] (Cabiralizumab) Monoclonal Antibody

Cabiralizumab is investigated for the treatment of Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma.

There are no reviews yet.

Be the first to review “Cabiralizumab Biosimilar – Anti-CSF1R, CD115 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products